Dr. Maggie Callahan Dr. Jedd Wolchok Dr. Ushma Neill Dr. Ruth Gotian
11:55-12:55pm
Workshop on Immune Monitoring
Dr. Phil Wong
12:55-1:25pm
30 min Lunch Break
BREAK
1:25-2:20pm
Clinical Trial Design and Statistical Consideration in the Development of IO
Dr. Katherine Panageas
2:20-3:00pm
Radiographic Endpoints for Immunotherapy Clinical Trial Design
Dr. Michael Postow
3:00-3:35pm
Integrating Radiation Oncology into IO Treatment
Dr. Christopher Barker
3:35-3:45pm
10 min Break
10 MIN BREAK
3:45-4:45pm
Investigating immunotherapy in underserved populations
Dr. Devika Jutagir
4:45-5:00pm
Take Homes
Jedd, Maggie, Ushma, Ruth
January 2023-MSKCC-Immuno-Oncology for the Translational Researcher Short Course (ITRSC)
About this course
The Memorial Sloan Kettering Cancer Center (MSKCC) Immuno-oncology for the Translational Researcher Short Course (ITRSC) is a cancer education and research experience that will enable eligible junior NCI-funded faculty to learn about tumor immunology, current immunotherapy-based clinical practice and cutting-edge translational research under the mentorship of expert MSKCC faculty. Program participants will attend an intensive 3-day virtual course, led by those centrally involved in basic and clinical immuno-oncology research. ITRSC participants will also have an opportunity to seek additional mentorship and guidance from world experts on immuno-oncology.
The objective of the ITRSC is to engage participants in an in-depth and participatory educational experience covering the topics relevant to clinical immunotherapy research and practice today: checkpoint blockade, novel immunomodulatory antibodies, cellular therapy, immune-monitoring, clinical trial design and development and points of integration with traditional cancer therapy.
